To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Glucosamine + chondroitin reduced joint space narrowing at 2 years vs. placebo in knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
July 2015

Glucosamine + chondroitin reduced joint space narrowing at 2 years vs. placebo in knee OA

Vol: 4| Issue: 7| Number:29| ISSN#: 2564-2537
Study Type:N/A
OE Level Evidence:1
Journal Level of Evidence:N/A

Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens

Ann Rheum Dis. 2015 May;74(5):851-8.

Contributing Authors:
M Fransen M Agaliotis L Nairn M Votrubec L Bridgett S Su S Jan L March J Edmonds R Norton M Woodward R Day LEGS study collaborative group

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

605 patients with osteoarthritis (OA) of the knee and resultant chronic knee pain were recruited to the study. Participants were randomized to consume glucosamine, chondroitin, a combination of both, or a placebo once daily for 2 years. The purpose of the study was to assess the effect on the supplements on joint space narrowing (JSN), pain, and function. The trial found that groups were comparabl...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue